Rubedo
Mohammad Nurul Huda, Ph.D. has a diverse work experience, beginning with a Laboratory Assistant role at North South University in 2016. In 2017, they began working at The University of Texas at El Paso as a Project Manager as Ph.D. Candidate and Graduate Research and Teaching Assistant. In 2021, they joined LAPIX Therapeutics as a Scientist I, Immunology. Most recently, they joined Rubedo Life Sciences in 2022 as a Scientist 1, In Vivo Pharmacology and Quantitative Biomarker. At Rubedo, they work on developing therapies to target cells which drive chronic age-related diseases.
Mohammad Nurul Huda, Ph.D. obtained their Bachelor of Science (BSc) in Biomedical/Medical Engineering from American International University-Bangladesh in 2016. Mohammad Nurul then went on to pursue their Doctor of Philosophy - PhD at The University of Texas at El Paso, which they completed in 2022. In addition, they have obtained several certifications, including Epidemics - the Dynamics of Infectious Diseases from Penn State University in 2020, Extracellular Vesicles in Health and Disease from Coursera in 2020, The Data Scientist’s Toolbox from Coursera in 2019, Programming of PLC for Industrial automation, maintain and troubleshooting of PLC system from Institution of Engineers, Bangladesh in 2015, Working with Mice in Research from CITI Program in 2019, Working with Rats in Research Settings from CITI Program in 2019, and Biomedical Science Responsible Conduct of Research from CITI Program in 2018.